Facts and figures
Placed initially on 4 November 2005 under the former company Biotec Pharmacon, ArcticZymes Technologies ASA is listed on the Oslo Stock Exchange. Being a global leader in development and commercialization of enzymes, we are working continuously on innovative, novel solutions and technologies. Our success stories is not only reflected in our current business figures but also the latest developments on the stock market. Take a look for yourself!
Reports and Finances
Get an insight into our current business developments with our quarterly reports.
Take a look at the current stock market price and our 20 largest shareholders.
More financial information
|02 Feb 2023||Presentation of the fourth quarter report 2022 and the preliminary annual accounts 2022|
|02 May 2023||Annual report 2022|
|04 May 2023||Presentation of the first quarter 2023|
|06 Jun 2023||Annual General Meeting|
|17 Aug 2023||Presentation of the second quarter 2023|
|02 Nov 2023||Presentation of the third quarter 2023|